Pull to refresh
Logo
UCSF gets federal funding for long COVID clinical trial network

UCSF gets federal funding for long COVID clinical trial network

Money Moves San Francisco, CA local

Defense Health Agency commits $7.1 million for PROBE-PASC

August 18th, 2026: Defense Health Agency awards $7.1M for PROBE-PASC

Overview

Updated 1 hour ago

The Defense Health Agency has committed $7.1 million to UC San Francisco for a clinical trial network studying the biological mechanisms of long COVID. The award, recorded Aug. 18, covers work starting Sept. 1 under the PROBE-PASC project.

The money is obligated, not spent. It is one piece of a federal research budget that UCSF, the largest public recipient of NIH funding, has seen come under pressure from proposed caps on indirect costs.

Why it matters

Long COVID has no proven mechanism-based treatment; this network is designed to find one.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

$7.1M
New federal award to UCSF
Obligated by the Defense Health Agency for PROBE-PASC; not yet spent.
$824M
UCSF's NIH funding in fiscal year 2025
Largest public recipient of NIH awards in the U.S. and second overall.
15%
Proposed NIH indirect cost cap
Blocked in court; would have cut UCSF funding by about $138 million per year.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

Play

Exploring all sides of a story is often best achieved with Play.

Most of these play right now — no account needed. Sign up to save scores, keep a streak, and unlock Debate and Predict. Log in Sign Up
Predict 3 ways this could play out. Back the one you believe — contrarian picks score more when a scenario has a resolution date. Log in to play

Organizations Involved

Timeline

February 2025 August 2026

4 events Latest: August 18th, 2026 · 2 weeks ago
Tap a bar to jump to that date
  1. Defense Health Agency awards $7.1M for PROBE-PASC

    Latest Funding

    The agency obligated $7.1 million to UCSF for a clinical trial network studying the biological pathways of long COVID. Work starts Sept. 1.

  2. UCSF closes FY 2025 with record NIH funding

    Milestone

    UCSF received $824 million in NIH awards, the most of any public university in the U.S.

  3. NIH proposes 15% cap on indirect costs

    Policy

    The National Institutes of Health announced a cap on facilities and administrative funding, threatening UCSF with about $138 million in annual losses.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

1987

AIDS Clinical Trials Group (1987)

The NIH created a national network for AIDS drug trials when HIV was untreatable.

Then

The network produced data leading to antiretroviral combinations.

Now

Turned AIDS from fatal to chronic and became a model for disease-specific trial networks.

Why this matters now

Shows a dedicated trial network can move an unknown syndrome toward treatment.

2021-2023

NIH RECOVER Initiative (2021)

Congress gave the National Institutes of Health $1.15 billion to study long COVID. The RECOVER program enrolled tens of thousands of patients but has not produced an approved treatment.

Then

Produced large observational datasets; no therapy.

Now

Made long COVID a named federal research priority.

Why this matters now

PROBE-PASC pursues the same goal with a different method: clinical trials designed to identify biological pathways.

Sources

(3)